back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-04 19:25 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,973
+2,751 vol $6.17 each |
5,804 | |
| Filed 2025-04-04 19:23 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-17,547.28
-3,368 vol $5.21 each |
26,730 | |
| Filed 2025-04-04 19:21 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-17,547.28
-3,368 vol $5.21 each |
15,455 | |
| Filed 2025-03-29 16:36 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$35,558
+5,726 vol $6.21 each |
18,823 | |
| Filed 2025-03-29 16:35 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$71,123
+11,453 vol $6.21 each |
30,098 | |
| Filed 2025-03-29 16:34 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,053
+17,561 vol $6.21 each |
33,716 | |
| Filed 2024-08-26 14:58 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,053 | ||
| Filed 2024-08-26 14:53 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
7,549 | ||
| Filed 2024-08-26 14:53 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
7,549 | ||
| Filed 2024-04-16 18:52 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:51 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-25 14:55 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,406
+16,155 vol $5.72 each |
16,155 | |
| Filed 2024-04-16 18:50 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,695
+16,087 vol $5.70 each |
||
| Filed 2024-04-16 18:53 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$31,623
+5,548 vol $5.70 each |
5,548 | |
| Filed 2024-04-16 18:52 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:51 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$63,247
+11,096 vol $5.70 each |
11,096 | |
| Filed 2024-04-16 18:51 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:50 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,695
+16,087 vol $5.70 each |
16,087 | |
| Filed 2024-04-16 18:50 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|